Brief: Nucana Presents Positive Data On Nuc-3373 At The 34Th Eortc-Nci-Aacr Annual Meeting 2022

NuCana

26/10/2022 12:07

Oct 26 (Reuters) - NuCana PLC  NCNA.O :
    * NUCANA PRESENTS POSITIVE DATA ON NUC-3373 AT THE 34TH
EORTC-NCI-AACR ANNUAL MEETING 2022
    * NUCANA PLC - NUCANA HAS INITIATED NUTIDE:303 STUDY OF
NUC-3373
IN COMBINATION WITH PEMBROLIZUMAB OR DOCETAXEL
    * NUCANA PLC - PEMBROLIZUMAB ACTIVITY INCREASED BY NUC-3373
IN
LUNG CANCER CELLS

Source text for Eikon:  ID:nGNX8TLfGc 
Further company coverage:  NCNA.O 
 ((Reuters.Briefs@thomsonreuters.com;))